Listen to The Lancet HIV: Recent Episodes
The Lancet HIV
The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title delivers a holistic view of the pandemic, publishing original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV.
Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV.
Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission.
Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la supresión viral.
Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo.
Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets.
Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America.
Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP.
Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.
Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV.
Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.
We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal.
Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.
Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.
Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.
Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.
Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.
Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa.
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.
Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.
Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.
Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B.
Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.
Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.
Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.
Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.
Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia.
Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.
Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV.
Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.
John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.
Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa.
Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.
Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean.
Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.
Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.
Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.
In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco.
Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).
Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services.
Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.
Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.
Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19.
Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris.
Adam Castillejo joins The Lancet HIV’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.
Deputy Editor Philippa Harris discusses viral load testing with Paul Drain (University of Washington, USA) and a trial of point-of-care testing with task shifting to improve treatment outcomes.
Joseph Kagaayi (Rakai Health Sciences Program, Uganda) and Oliver Ratman (Imperial College London, UK) talk to Editor-in-Chief Peter Hayward about the world famous research site and the insights that deep sequencing has provided into the flow of HIV in their latest research.
Marta Nunes (University of the Witwatersrand, Johannesburg, South Africa) talks to Philippa Harris about vaccination response in people living with HIV and a trial of influenza vaccine dosing in pregnant women with HIV in South Africa.
For World AIDS day, The Lancet HIV Deputy Editor Philippa Harris talks to Jeff Lazarus and Nikos Dedes about the importance of good health-related quality of life and the barriers people living with HIV face in achieving this.
Giuseppe Pantaleo (Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Switzerland) tells Peter Hayward about a phase 1 vaccine study published in the November issue of The Lancet HIV, and gives an overview of the HIV vaccine field.
Julia Marcus and Douglas Krakower talk to Peter Hayward about the use of electronic health record data to predict HIV risk and identify PrEP candidates.
The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure
The Lancet HIV Deputy Editor Philippa Harris talks to Betsy Herold (Albert Einstein College of Medicine, USA) about her trial investigating a tenofovir disoproxil fumarate intravaginal ring for pre-exposure prophylaxis in sexually active women.
Sheree Schwartz (Johns Hopkins School of Public Health) talks to The Lancet HIV Editor-in-Chief Peter Hayward about the Sakh'umndeni Safer Conception Project safer conception project for South African couples living with HIV.
Sunil Solomon (Johns Hopkins School of Medicine, USA) discusses the trials and tribulations of investigating integrated HIV testing, prevention, and treatment centres for people who inject drugs and men who have sex with men in India.
The Lancet HIV Editor Peter Hayward talks to Evgeny Krupitsky about a trial investigating the potential of slow-release naltrexone to improve HIV treatment adherence in drug users in St Petersburg.
The Lancet HIV Deputy Editor Liz Zuccala joins Stephanie Cohen to discuss a case report of an individual who acquired HIV despite reporting good adherence to PrEP.
For World AIDS Day we explore how, despite huge advances, children are affected by HIV in 2018. We speak to Martina Penazzato of WHO on drug options and development, to Mark Cotton (Stellenbosch University) on the course of HIV management from infancy to adolescents (12 min 03), and to Tamsen Rochat (Human Sciences Research Council in South Africa) on how HIV still impacts the lives of children who don’t have the virus (26 min 33).
Andrew Grulich joins The Lancet HIV editor-in-chief Peter Hayward to discuss the EPIC-NSW study, looking at the population-level effectiveness of PrEP in New South Wales, Australia.
Peter Hayward and Gregg Gonsalves discuss a new modelling study looking at an outbreak of HIV in Scott County, Indiana, USA.
Peter Hayward, editor-in-chief of The Lancet HIV, talks to Sanne van Luenen about her recent work on a new intervention for individuals with HIV and depressive symptoms.
Frances Mary Cowan, an author of the SAPPHI-IRe trial, talks to The Lancet HIV about efforts to improve HIV services for this key population in Zimbabwe.
Geoffrey Gottlieb and Robert Smith talk with The Lancet HIV about enhancing care and clinical management of patients infected with HIV-2.
Manon Ragonnet-Cronin joins The Lancet HIV Editor, Peter Hayward, to discuss the use of phylogenetic analysis to gain insight into HIV transmission in the UK, the potential role of non-disclosed MSM, and targeting of HIV interventions.
Editor-in-Chief of The Lancet HIV Peter Hayward discusses the new look journal and talks to Louise Kuhn, an author of the journal's first Review, about the opportunities and possibilities of starting antiretroviral therapy soon after birth in infants with HIV.
Francois Dabis discusses his paper on universal test and treat and the HIV epidemic in rural South Africa.
Linda-Gail Bekker discusses her trial of the feasibility of non-daily pre-exposure prophylaxis dosing on African women.
Steven Goodreau and Eli Rosenberg explain their modelling of the causes of disparities in HIV incidence among black and white men who have sex with men in Atlanta, GA, USA.
Beatriz Grinsztejn discusses the prevalence of HIV among transgender women in Rio de Janeiro, Brazil.